Grand Hôpital de Charleroi
17
5
5
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.8%
2 terminated/withdrawn out of 17 trials
81.8%
-4.7% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.
Role: lead
Assessing the Japet.W+ Lumbar Traction Device in Rehabilitation for Patients With Non-specific Mechanical Low Back Pain
Role: lead
Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation
Role: lead
Effect of IMT in Patients After Acute Exacerbations of COPD
Role: collaborator
Prospective Observational Study of Diffuse Large-cell B Lymphoma
Role: lead
PoCUS Diagnostic Accuracy for Fecal Impaction in the Emergency Department: A Prospective Study
Role: collaborator
Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer
Role: lead
ESKETamine for FIBromyalgia Treatment
Role: lead
Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.
Role: lead
Comparative Study of the Performance of Drug Anamneses in an Emergency Department
Role: lead
Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)
Role: collaborator
PAtient-PHYsician Relationship Assessment
Role: collaborator
Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
Role: collaborator
Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members
Role: lead
COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020
Role: lead
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
Role: collaborator
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Role: collaborator
All 17 trials loaded